SCHEMBL19016325

SCHEMBL19016325

CC(COCCNC(=O)OCc1ccccc1)CC(=O)OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.60
LMNA P02545 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.48
SYK P43405 1/20 0.47
MAPT P10636 2/20 0.47
IDO1 P14902 1/20 0.47
HTT P42858 2/20 0.45
CTSS P25774 1/20 0.43
PPARA Q07869 1/20 0.43
SLC1A3 P43003 1/20 0.42
SLC1A1 P43005 1/20 0.42
TGM2 P21980 1/20 0.41
KLK7 P49862 1/20 0.41
KLK5 Q9Y337 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19016323 0.86 SMN1; SMN2 (0.68) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL20136946 0.84 SMN1; SMN2 (0.68) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL1668653 0.83 SMN1; SMN2 (0.71) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL29323231 0.83 SMN1; SMN2 (0.70) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL26985988 0.82 PPARA (0.52) L3MBTL1SYKCTSSPPARASLC1A1
SCHEMBL24572425 0.82 SMN1; SMN2 (0.69) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL4513964 0.82 SMN1; SMN2 (0.69) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL20526175 0.82 SMN1; SMN2 (0.69) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL18886286 0.82 SMN1; SMN2 (0.69) SMN1; SMN2LMNAL3MBTL1SYKMAPT
SCHEMBL29323035 0.82 SMN1; SMN2 (0.68) SMN1; SMN2LMNAL3MBTL1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017103824-A1 TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS NOVARTIS AG (CH) 2017-06-22 WO disclosed